#Paranoia

A new wave of scientific research challenges some of the most common beliefs about using cannabis to treat health problems such as pain, insomnia, and mental health symptoms like paranoia, highlighting important lessons for Thai readers at a time when medical marijuana access is rapidly expanding in Thailand and across Asia.

The use of cannabis as medicine has surged since Thailand became the first Southeast Asian country to decriminalize cannabis plants in 2022—a move initially aimed to stimulate medical innovation and boost the economy through wellness tourism. But as ever more Thais purchase cannabis products online and at street dispensaries, fresh global research underscores that the effectiveness—and risks—of cannabis for many health problems are far from settled, with strong implications for the Thai public, patients, and caregivers (Washington Post, Medical News Today).

A surge of recent research questions common beliefs about cannabis as a medicine for pain, insomnia, and mental health symptoms such as paranoia. The findings matter for Thai readers as medical cannabis access expands in Thailand and across Asia.

Cannabis has entered mainstream health discussions since Thailand decriminalized cannabis plants in 2022. The move aimed to spur medical innovation and wellness tourism. Yet as more Thais buy cannabis products online and at street dispensaries, new global research shows that evidence on effectiveness and risks is far from settled. This has clear implications for patients, caregivers, and clinicians in Thailand.

New global research paints a nuanced picture of cannabis’ effects on insomnia, chronic pain, and anxiety. Large studies from Australia and the United States show real improvements in quality of life for some patients, but also raise concerns about potential mental health risks such as paranoia, psychosis, and broader psychiatric issues.

For Thai readers, the findings emphasize a careful, evidence-based approach as Thailand continues to navigate its cannabis policy changes. The latest research offers cautious optimism about therapeutic potential while underscoring the need for robust safeguards and education.

Amid rising global interest and legal reforms surrounding cannabis, recent research is painting a complex picture of its true effects on common health problems such as insomnia, chronic pain, and anxiety. A series of large-scale studies from Australia to the United States highlight encouraging long-term improvements in quality of life for patients with stubborn conditions, but also raise serious caution about potential mental health risks such as paranoia, psychosis, and increased risk of psychiatric disorders.